Pathology Doctors in Bemidji, MN Accepting Medicare

4 Pathology doctors found. Showing 1 - 4

Angela Joy Wood, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 1300 Anne St Nw, Bemidji, MN 56601 Phone: 218-333-5000

Dr. Lisa A. Lund, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 1300 Anne St Nw, Bemidji, MN 56601 Phone: 218-333-4815

Paul J Lappinga, MD Pathology - Cytopathology Medicare: Accepting Medicare Assignments Practice Location: 1300 Anne St Nw, Bemidji, MN 56601 Phone: 218-333-4813

Glen Mark Robia, MD Pathology - Anatomic Pathology Medicare: Not Enrolled in Medicare Practice Location: 1233 34th St Nw, Bemidji, MN 56601 Phone: 218-333-5000    Fax: 218-333-5958

News Archive

Study of Millennials highlights social media behaviors linked with major depression

Certain social media factors were linked with major depressive disorder (MDD) in a Journal of Applied Biobehavioural Research study of Millennials.

Dramatic growth in number of hospitalists over last two decades

One of the most striking changes in health care over the last two decades has been a dramatic increase in physicians categorized as "hospitalists" - doctors who practice almost exclusively in hospitals, rather than combining both outpatient and inpatient care.

New technique to rehabilitate damaged lungs could benefit many transplant patients

A new technique to rehabilitate lungs that are too damaged to be considered for transplant could benefit an increasing population of patients with end-stage lung disease.

Early treatment may prevent clotting in COVID-19 vaccine-related thrombocytopenia

Now, a new report in the Journal of Thrombosis and Hemostasis reveals that timely diagnosis and treatment of this condition may prevent further morbidity and mortality, and enable the vaccine to be used widely with confidence.

Cell Therapeutics enters securities purchase agreement with single life sciences institutional investor

Cell Therapeutics, Inc. today announced that it has entered into a securities purchase agreement to sell, subject to certain closing conditions, up to $25.0 million of shares of its Series 8 Non-Convertible Preferred Stock, warrants to purchase up to 22,563,177 shares of common stock and an additional investment right to purchase up to $25.0 million of shares of its Series 9 Convertible Preferred Stock, in a registered offering to a single life sciences institutional investor.

Read more Medical News

› Verified 9 days ago